Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Panakès Partners is a venture capital firm established in 2015, based in Italy, that specializes in life sciences investments. The firm was founded by Fabrizio Landi, Alessio Beverina, and Diana Saraceni, who collectively bring extensive experience in the healthcare sector. Panakès Partners primarily targets early-stage startups and small to medium-sized enterprises (SMEs) across Europe and Israel, focusing on innovative products that address significant medical needs.
Currently, Panakès Partners manages assets totaling $250 million, with a fund size of $180 million. The firm has made a notable impact in the life sciences sector, collaborating with a network of clinicians and industry experts to enhance the development of its portfolio companies. The firm’s commitment to integrating environmental, social, and governance (ESG) principles into its investment processes further distinguishes it in the venture capital landscape.
Panakès Partners invests in life sciences technologies that aim to improve or solve health conditions. The firm focuses on early-stage startups and SMEs, providing both financial and business support. Their check sizes range from $3 million to $8 million, allowing them to make significant investments in promising companies. The firm emphasizes collaboration with clinicians and industry experts to accelerate the development of its portfolio companies, ensuring that they are well-positioned to address critical medical needs.
The sectors of interest for Panakès Partners include biotech, healthcare, dermatology, surgery, ophthalmology, cardiovascular, oncology, in-vitro diagnostics, neuromodulation, and regenerative medicine. Their investment strategy is designed to identify ambitious entrepreneurs who are developing innovative solutions in these fields. Additionally, Panakès Partners integrates ESG principles into its investment processes, reflecting a commitment to not only financial returns but also positive societal impact.
Panakès Partners has built a diverse portfolio that spans various medical fields, showcasing their commitment to addressing pressing health challenges. The portfolio includes:
This diverse range of technologies highlights Panakès Partners' focus on innovative health solutions that address significant medical needs.
Fabrizio Landi - Founder and Managing Partner. Fabrizio has extensive experience in the healthcare sector and has been instrumental in establishing Panakès Partners as a leading venture capital firm in life sciences.
Alessio Beverina - Founder and Managing Partner. Alessio brings a wealth of knowledge in investment management and has played a key role in the firm's strategic direction.
Diana Saraceni - Founder and Managing Partner. Diana has a strong background in life sciences and contributes to the firm's focus on innovative health technologies.
Barbara Castellano - Partner. Barbara has significant experience in venture capital and supports the firm's investment activities.
Rob Woodman - Partner. Rob specializes in life sciences investments and works closely with portfolio companies to drive growth.
Marco Sardina - Scientific Partner. Marco provides scientific expertise and guidance to the firm's investment decisions.
Alessio Piuma - Principal. Alessio focuses on sourcing and evaluating new investment opportunities.
Andrea Ballerini - Investment Manager. Andrea manages the firm's investment portfolio and supports portfolio companies.
Giacomo Piccinini - Investment Manager. Giacomo is involved in deal sourcing and due diligence processes.
Annalisa Coraducci - Senior Analyst. Annalisa conducts market research and analysis to support investment decisions.
Lorenzo Giordano - CFO. Lorenzo oversees the firm's financial operations and reporting.
Paola Crovato - Office and Deal Flow Manager. Paola manages the firm's office operations and deal flow processes.
Federica Porcu - Financial Controller and ESG Manager. Federica ensures compliance with financial regulations and oversees ESG initiatives.
Michela Barcella - Network and Portfolio Talent Advisor. Michela supports portfolio companies in talent acquisition and development.
To pitch to Panakès Partners, founders should submit their proposals through the firm's website at www.panakes.it. The pitch deck should include a clear overview of the business model, market opportunity, competitive landscape, and the team’s qualifications. Founders are encouraged to provide data supporting their claims and any existing traction.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can enhance the chances of securing a meeting with the investment team.
In March 2026, Panakès Partners announced the final close of their Purple Fund (Fund II) at €175 million, marking it as the largest life sciences VC fund in Italy. The first close was reported at €150 million, with significant backing from Menarini, a prominent pharmaceutical company. The fund focuses on active deployment across Europe and Israel, emphasizing investments in innovative health technologies.
Additionally, the European Investment Fund (EIF) confirmed its backing during the first close announcement, highlighting the fund's credibility and potential for impactful investments in the life sciences sector.
What are Panakès Partners' investment criteria?
Panakès Partners focuses on early-stage startups and SMEs in the life sciences sector, particularly those developing innovative technologies that address critical health conditions. They invest in various fields, including biotech, healthcare, dermatology, and oncology.
How can startups apply or pitch to Panakès Partners?
Startups interested in pitching to Panakès Partners can visit their website at www.panakes.it for more information on the application process. They encourage direct submissions through their online platform.
What makes Panakès Partners different from other venture capital firms?
Panakès Partners distinguishes itself by integrating ESG principles into its investment processes and collaborating closely with a network of clinicians and industry experts to support the development of its portfolio companies.
What is the geographic scope of Panakès Partners' investments?
The firm primarily invests in Europe and Israel, focusing on early-stage life sciences companies that have the potential to make a significant impact on health outcomes.
What is the typical fund size and check size for Panakès Partners?
Panakès Partners has a fund size of $180 million, with check sizes ranging from $3 million to $8 million for their investments in early-stage startups and SMEs.
What kind of post-investment involvement does Panakès Partners have?
Panakès Partners provides both financial and business support to its portfolio companies, leveraging its network of clinicians and industry experts to accelerate their development and ensure successful outcomes.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.